Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia

Conditions:   Acute Myeloid Leukemia;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Acute Myeloid Leukemia With Multilineage Dysplasia;   Myeloid Sarcoma;   Secondary Acute Myeloid Leukemia;   Therapy-Related Acute Myeloid Leukemia;   Therapy-Related Myelodysplastic SyndromeInterventions:   Drug: Cytarabine;   Drug: VosaroxinSponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)Not yet recruiting - verified January 2016

Source: ClinicalTrials.gov - January 14, 2016 Category: Research Source Type: clinical trials